The long-term goal of this research is to develop a successful approach to in utero stem cell transplantation in human fetuses diagnosed with immunodeficiency diseases, hemoglobinopathies, or inborn errors of metabolism. In an in utero murine model of hematopoietically non-defective mice, while 70% engraft, the percent of donor cells is low (.001-2%). However, most engrafted animals are partially tolerant to donor skin grafts; some show permanent skin graft acceptance, and a few have no evidence of tolerance to skin grafts.
The specific aim of this application is to define the mechanisms that are responsible for the in utero induction of tolerance to allogeneic donor cells. The hypotheses that will be tested are: 1) The limited number of allogeneic mismatched hematopoietic stem cells (HSC) that engraft in utero can be expanded and differentiate into multilineages in non-defective recipients, and 2) tolerance of the host to allogeneic mismatched HSC is mediated by marrow derived donor dendritic cells (DC) and T cells. Cytokine-recruited peripheral blood stem cells will be used to determine the optimal number of cells required to achieve engraftment, and engrafted cells in the thymus, spleen, lymph node, blood, liver, and marrow will be phenotyped. Experiments will be carried out to determine whether deletion in the thymus (or periphery) is involved in tolerance induction in engrafted mice and what role anergy plays centrally and/or in the periphery. Results of the proposed experiments will lead to the development of therapeutic strategies for the optimization of engraftment of donor cells pre and postnatally and could have an impact on other areas of transplantation, specifically, induction and maintenance of tolerance to solid organs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058842-03
Application #
6139258
Study Section
Special Emphasis Panel (ZRG2-ET-2 (03))
Project Start
1998-01-01
Project End
2001-12-31
Budget Start
2000-02-15
Budget End
2001-12-31
Support Year
3
Fiscal Year
2000
Total Cost
$191,030
Indirect Cost
Name
University of California San Francisco
Department
Pediatrics
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Xiao, Tony Z; Singh, Kanal; Dunn, Elizabeth et al. (2012) T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells. Biol Blood Marrow Transplant 18:200-9
Xiao, Zheng; Yannone, Steven M; Dunn, Elizabeth et al. (2009) A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories. Eur J Hum Genet 17:205-12
Xiao, Zheng; Dunn, Elizabeth; Singh, Kanal et al. (2009) A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:1-11
Povirk, Lawrence F; Zhou, Tong; Zhou, Ruizhe et al. (2007) Processing of 3'-phosphoglycolate-terminated DNA double strand breaks by Artemis nuclease. J Biol Chem 282:3547-58
Bhattacharyya, Swati; Cowan, Morton J (2005) B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 11:657-71
Bhattacharyya, Swati; Chawla, Anjulika; Smith, Kristofer et al. (2002) Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice. J Immunol 169:6133-40
Cowan, M J; Chou, S H; Tarantal, A F (2001) Tolerance induction post in utero stem cell transplantation. Ernst Schering Res Found Workshop :145-71
Chou, S H; Chawla, A; Lee, T H et al. (2001) Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model. Transplantation 72:1768-76